Differential NF-κB and MAPK activation underlies fluoride- and TPA-mediated CXCL 8 (IL-8) induction in lung epithelial cells by Refsnes, Magne et al.
© 2014 Refsnes et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Journal of Inflammation Research 2014:7 169–185
Journal of Inflammation Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
169
O R I g I n a l  R e s e a R c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/JIR.S69646
Differential nF-κB and MaPK activation underlies 
fluoride- and TPa-mediated cXcl8 (Il-8) 
induction in lung epithelial cells
Magne Refsnes
Tonje skuland
Marit låg
Per e schwarze
Johan Øvrevik
Department of air Pollution and 
noise, Division of environmental 
Medicine, norwegian Institute of 
Public health, Oslo, norway
correspondence: Magne Refsnes 
Department of air Pollution and noise, 
Division of environmental Medicine, 
norwegian Institute of Public health, 
PO Box 4404 nydalen, n-0403 Oslo, 
norway 
Tel +47 210 765 33 
Fax +47 210 766 86 
email magne.refsnes@fhi.no
Abstract: Different toxic agents have a varying potential to induce the production of the proin-
flammatory chemokine, CXCL8 (interleukin [IL]-8), in lung cells. A critical question is which 
mechanisms determine the magnitude and persistence of the CXCL8 responses to different 
stimuli. To approach this, we compared the potential of the phorbol ester, 12-O-tetradecanoylphor-
bol-13-acetate (TPA), and sodium fluoride (NaF) to induce CXCL8 responses in A549 cells, 
with emphasis on the importance of nuclear factor kappa B (NF-κB)- and mitogen-activated 
protein kinase (MAPK) signaling. Notably, TPA induced a greater release of CXCL8 than did 
NaF. Furthermore, TPA induced a strong, rapid, but transient upregulation of CXCL8 messenger 
(m)RNA, whereas NaF induced a weaker, more delayed, but persistent upregulation. With respect 
to signaling, TPA led to an early, strong, and relatively transient extracellular signal-regulated 
kinase (ERK)1/2 phosphorylation, and a less marked and even more transient phosphorylation 
of c-jun-N-terminal kinases (JNK1/2) and p38. In contrast, NaF elicited a lower, but relatively 
sustained increase in phosphorylation of ERK1/2, and a marked phosphorylation of p38 and 
JNK1/2, with the JNK1/2 response as most transient. Only ERK1/2 inhibition affected the TPA 
response, whereas inhibition of all the three MAPK cascades reduced NaF-induced CXCL8 
release. TPA also induced an early, marked phosphorylation/translocation of p65 (NF-κB), 
whereas NaF induced slower, less pronounced effects on p65. The CXCL8 responses by TPA 
and NaF were reduced by p65-siRNA. In conclusion, all MAPK cascades were involved in 
NaF-induced CXCL8 release, whereas only ERK1/2 activation was involved in response to 
TPA. Furthermore, NF-κB activation appeared to be indispensable for CXCL8 induction. The 
early response, magnitude, and persistency of MAPK and NF-κB signaling seemed to be critical 
determinants for the potential to induce CXCL8. These findings underscore that a strong, rapid, 
and relatively transient activation of ERK1/2 in combination with NF-kB may be sufficient 
for a strong induction of CXCL8, which may exceed the effects of a more moderate ERK1/2 
activation in combination with activation of p38, JNK1/2, and NF-κB.
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Introduction
The chemokine CXCL8 (interleukin [IL]-8) plays a crucial role in lung inflammation 
by recruiting neutrophils to the sites of injury or infection.1 Elevated CXCL8 levels 
are typical in airway diseases such as chronic obstructive pulmonary disease, cystic 
fibrosis, and severe asthma, and are believed to be an important factor in the patho-
genesis of such disorders.2–4 In addition, CXCL8 also has mitogenic, motogenic, and 
angiogenic properties and may contribute to cancer development.5 Thus, elucidating 
the mechanisms of CXCL8 regulation is of considerable therapeutic interest.
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Activation of CXCL8 production is known to be 
mediated via several signal pathways, including different 
mitogen-activated protein kinases (MAPKs) and the nuclear 
factor kappa B (NF-κB) transcription factor. The MAPKs are 
members of a family of serine-threonine kinases, to which 
many externally activated signaling pathways converge.6 Both 
extracellular signal-regulated kinase-1 and -2 (ERK1/2), the 
c-jun-N-terminal kinases (JNK1/2), and the p38 MAPKs 
seem to influence CXCL8 synthesis, the contribution of 
each depending on the cell type and stimulant.7–13 The cen-
tral element of the classical NF-κB pathway is a homo- or 
heterodimer, most typically consisting of the p65/p50 dimer, 
which within resting cells is inactivated in the cytosol due 
to binding to IκB. Upon stimulation, IκB is phosphorylated, 
ubiquitinated, and degraded, thus allowing p65/p50 to translo-
cate to the nucleus and bind to κB-sites in promoters of target 
genes.14 NF-κB signaling is regarded as indispensable for 
inducible CXCL8 regulation. The effect of NF-κB activation 
alone on the CXCL8 response is, however, normally marginal. 
Therefore, a combined activation of NF-κB and at least one of 
the main MAPK cascades are required to stimulate any con-
siderable increase in CXCL8 production. Maximal CXCL8 
responses are believed to require a combined activation of 
NF-κB along with all the three main MAPK cascades.15 In 
particular, post-transcriptional stabilization of CXCL8 mes-
senger (m)RNA by p38 has been suggested to be essential to 
achieve high levels of CXCL8 release, as CXCL8 mRNA oth-
erwise is highly unstable and degrades rapidly in the absence 
of p38 activity.15 The MAPK and NF-κB cascades are usually 
regarded as separate pathways. However, it has also been 
reported that MAPK activation may be localized upstream 
to the activation of NF-κB, possibly depending on both the 
stimulator and cell type.12,16–19
A large range of toxic agents are known to interact with 
the lung epithelial cell layer, triggering innate immune 
responses and the release of proinflammatory cytokines, 
including CXCL8.20 However, the ability to stimulate CXCL8 
production varies considerably. Proinflammatory cytokines, 
such as IL-1 and tumor necrosis factor (TNF)-α, may upregu-
late CXCL8 release by 100-fold, while other agents cause 
more moderate 5–10-fold increases.15 An important question 
is which mechanisms determine the magnitude and persis-
tence of the observed CXCL8 responses. We have previously 
reported varying potentials to induce CXCL8 responses in 
lung cells by different toxic agents.21–26 Of note, the phorbol 
ester,  12-O-tetradecanoylphorbol-13-acetate (TPA), induced 
a strong CXCL8 response in A549 cells that markedly 
exceeded the effect of sodium fluoride (NaF),9 and with a 
different time course of response. TPA, a classical promoting 
agent in studies of cancer development, is a rapid and strong 
activator of protein kinase C (PKC), and also a potent MAPK 
activator.27 TPA usually seems to exert its cellular effects via 
ERK1/2 activation,18,19 although it has also been reported that 
TPA may activate p38.28 Fluoride exposure in the form of 
hydrogen fluoride is involved in airway disease, as reflected 
by an association with occupational asthma in epidemiologic 
studies,29 and with respiratory inflammation in experimental 
human clinical studies.30,31 To investigate how these effects 
might be elicited, mechanistic studies of fluoride responses 
are of essence. In addition to our previous in vitro studies 
on fluoride exposure in lung epithelial cells,8,9,26,32–34 several 
mechanistic studies on fluoride exposure have emerged the 
recent years, including studies on the role of MAPK in COX-2 
upregulation in lung epithelial cells,35 on oxidative stress and 
lipoxygenase activity in monocytes/macrophages,36,37 and 
on MAPK and oxidative stress in microglia cells.38 NaF has 
been reported to mediate its effect via a persistent G-protein 
activation and/or phosphatase inhibition.39,40 In A549 cells, 
NaF induced a weak, delayed, but persistent PKC activation, 
in contrast to TPA that elicited a strong, rapid, but transient 
effect. Upon PKC inhibition, the stimulatory effect of TPA on 
CXCL8 release was nearly abolished, whereas the response of 
NaF on CXCL8 release was only partially reduced.9 Further-
more, NaF elicited a persistent activation/phosphorylation of 
MAPKs, involving both EGF receptor and Src-dependent 
processes in A549 cells. The NaF effect was partially reduced 
by the inhibition of the MAPKs ERK1/2, p38, and JNK1/2, 
respectively, whereas the combined inhibition of different 
MAPKs (p38/JNK, p38/ERK1/2, and ERK1/2/JNK1/2) 
completely abolished the response.8,9,33 In the present study, 
we have compared the CXCL8 responses induced by TPA and 
NaF with respect to the involvement of MAPK and NF-κB 
pathways, with emphasis on the magnitude and duration of 
the response.
Materials and methods
Reagents
Nutrition mixture F12 HAM Kaighn’s modification culture 
medium was obtained from Sigma-Aldrich Co. (St Louis, MO, 
USA). Fetal bovine serum (FBS) was from EuroClone SpA 
(Milano, Italy). Ampicillin and fungizone were purchased 
from Bristol-Myers Squibb (New York, NY, USA) and peni-
cillin/streptomycin from BioWhittaker® (VWR International, 
Radnor, PA, USA). NaF was obtained from Honeywell 
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International, Inc. (Morristown, NJ, USA). TPA, SB202190, 
PD98059, SP600125, curcumin, MG132, and BAY11-7082 
were purchased from Calbiochem-Novabiochem Corporation 
(San Diego, CA, USA); phenylmethylsulfonyl fluoride and 
pyrrolidine dithiocarbamate (PDTC) were from Sigma-
Aldrich Co. JNK2 SMARTpool small interfering (si)RNA 
reagent against JNK2 and nonspecific control pool (negative 
control) were from Upstate Biotechnology, Inc. (Lake Placid, 
NY, USA). HiPerFect transfection reagent was from  Qiagen 
NV (Venlo, the Netherlands). SiRNA against p65 and nonsense 
siRNA were from Cell Signaling  Technology, Inc. (Danvers, 
MA, USA). Cytokine ELISA assay for human CXCL8 (IL-8) 
(Cyto-Set® CHC1304) was supplied by Thermo Fisher Sci-
entific (Waltham, MA, USA). Acrylamide/Bis-acrylamide 
mix (30%), TEMED, and Bio-Rad DCTM Protein Assay were 
from Bio-Rad Laboratories Inc. (Hercules, CA, USA). The 
Compartment Protein Extraction Kit was from BioChain Insti-
tute, Inc. (Newark, CA, USA). The Absolutely RNATM reverse 
transcription (RT) polymerase chain reaction (PCR) Miniprep 
kit was from Stratagene California (La Jolla, CA, USA). The 
predesigned TaqMan® Gene Expression Assays, TaqMan 
Universal PCR Master Mix, and the High-Capacity cDNA 
Archive Kit were purchased from Thermo Fisher  Scientific. 
SuperSignal® West Dura chemoluminiscence system was 
obtained from Thermo Fisher Scientific, and the stripping 
solution (Mild Antibody Stripping Solution®) was obtained 
from Chemicon International, Inc. (Billerica, MA, USA). All 
other chemicals were purchased from commercial sources at 
the highest purity available.
antibodies
Specific antibodies against phospho-p38 (Thr180/Tyr182), 
p38, phospho-JNK1/2 (Thr183/Tyr185), JNK 1/2, IκBα, 
phospho-IκBα (Ser32), p65, phopho-p65 (Ser536), glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH), and histon 
H1 were obtained from Cell  Signaling Technology, Inc. 
Antibodies against phospho-ERK1/2 (Tyr-204) were obtained 
from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). The 
antibody against JNK2 was from Upstate Biotechnology, 
Inc., and the antibody against β-actin was obtained from 
Sigma-Aldrich Co.
cell cultures and exposure
A549 cells, a human epithelial lung cell line, from the 
 American Type Culture Collection (Manassas, VA, USA) were 
cultured in F12 HAM Kaighn’s modification medium, supple-
mented with ampicillin (0.1 mg/mL), penicillin (0.1 mg/mL), 
streptomycin (0.1 mg/mL), fungizone (0.25 µg/mL), and 10% 
heat-inactivated FBS. The cells (passage number 79–100) 
were plated in 35 mm six-well culture dishes (2×104 cells/
well) and grown to near confluency at 37°C in a humidi-
fied atmosphere of 5% CO
2
 in air. The cells were exposed 
to varying concentrations of NaF (1.0–3.75 mM) and TPA 
(1–100 nM) for the indicated periods of time. When used, 
pharmacological inhibitors were added 1 hour prior to NaF 
or TPA exposure and kept in the culture medium during the 
whole incubation period. The concentrations of MAPK inhibi-
tors PD98059 (25 µM), SB202190 (10 µM), and SP600125 
(20 µM) were based on previous studies of concentration–
response relationships for the respective inhibitors.9 For the 
NF-κB inhibitors, different concentrations were examined: 
curcumin (0–100 µM); MG132 (0–10 µM); BAY11-7082 
(0–10 µM); or PDTC (0–75 µM).
separation of nuclei and cytosol
For the extraction of nuclei and cytosol, we used a 
Compartment Protein Extraction Kit from BioChain Institute, 
Inc. The cells were lysed, and cytosolic and nuclei proteins 
were isolated according to producer’s recommendations. 
Protein concentrations in the lysate fractions were measured 
by Bio-Rad DC Protein Assay. Then, 6 µg of protein were 
loaded on a 10% Acrylamide/Bis gel. The amounts of p65 in 
the cytosolic and nuclei fractions were analyzed by Western 
blotting.
Transfection with siRna against JnK  
and p65
A549 cells at a density of 200,000 cells/well were transfected 
with 10 nM siRNA against JNK2 and p65, using HiPerfect 
transfection reagent (18 µL/well) according to the procedure 
by Qiagen NV using the fast-forward protocol.41 The effec-
tiveness of gene silencing was analyzed by Western blotting 
at 48 hours, 72 hours, or 96 hours by measuring the JNK2 and 
p65 protein levels in relation to β-actin. A negative siRNA 
control, SMARTpool (Upstate Biotechnology, Inc.), was used 
for the JNK experiments and SignalSilence® Control siRNA 
for the p65 experiments. Cells transfected with siRNA against 
JNK2 and p65 or negative control siRNA were exposed to 
NaF and TPA for 20 hours, 48 hours after transfection, and 
CXCL8 levels were measured by ELISA.
Measurements of cXcl8
CXCL8 protein levels in the cell medium were determined 
by ELISA assay. The growth medium was harvested and 
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centrifuged at 250× g to remove cells. The final super natants 
were stored at -70°C. CXCL8 levels were determined accord-
ing to the manufacturer’s guidelines. Absorbance was measured 
and quantified using a plate reader (SunriseTM; Tecan Trading 
AG, Maennedorf, Switzerland) complete with software 
(Magellan version 1.10), and color intensity was converted to 
nanograms of CXCL8 using appropriate standards.
Measurements of cXcl8 mRna
CXCL8 mRNA levels were determined by real-time PCR. 
Total mRNA was isolated from cells according to the sup-
plier’s recommendations using the Absolutely RNATMRT-
PCR Miniprep kit, and reverse transcribed to cDNA on a 
PCR System 2400 (PerkinElmer) using a High-Capacity 
cDNA Archive Kit (Applied Biosystems; Thermo Fisher 
Scientif ic). Real-time PCR was performed using the 
Applied Biosystems 7500 Real-Time PCR System, with 
predesigned TaqMan Gene Expression Assays (18S, 
Hs99999901_s1 and CXCL8, Hs00174103_m1) and 
TaqMan Universal PCR Master Mix. For these analyses, 
1 µg of total RNA was reverse transcribed to complemen-
tary (c)DNA using a High-Capacity cDNA Archive Kit. 
The cDNAs were diluted 1:20 in a solution of nuclease-free 
water, TaqMan Universal Master Mix, primers, and probe 
before performing the real-time PCR. The expression of 
each gene of interest (GOI) in each sample was normal-
ized against housekeeping genes (HKG), and expressed 
as the fold change compared to the untreated control, as 
calculated by the ∆∆Ct-method:
  ∆Ct = Ct(GOI) - Ct(HKG) (1)
  ∆∆Ct = ∆Ct(treated) -∆Ct(control) (2)
 Fold change = 2(-∆∆Ct)  (3)
Immunoblotting
Total and phosphorylated protein levels were detected 
by Western blotting. Cells were resuspended in ice-cold 
lysis buffer (20 mM Tris-HCL; pH=7.5; 150 mM NaCl; 
1 mM EDTA; 1 mM EGTA; 2.4 mM Na-pyrophosphate; 
1.0 mM orthovanadate; 1 mM NaF; 21 mM leupeptin; 
1.5 mM aprotinin; 15 mM pepstatin A; and 1% TritonTM-X), 
sonicated for 5×1 second, and centrifuged for 8,000× g 
for 10 minutes. Protein determination was done in the 
supernatant by the Bio-Rad DC Protein Assay. Proteins 
(12.5 µg/well) from whole-cell lysates were separated 
by 10% SDS-PAGE and blotted onto nitrocellulose 
membranes. To ensure that the protein levels of each 
well were equal, Ponceau staining was used for loading 
control. The membranes were then probed with antibodies 
against the respective phosphorylated MAPKs (p-ERK1/2, 
p-JNK1/2, or p-p38) prior to incubation with horseradish 
peroxidase-conjugated secondary antibodies. The blots 
were developed using the SuperSignal West Dura chemolu-
miniscence system according to the manufacturer’s 
instructions. Finally, the membranes were stripped by 
incubation for 15 minutes at room temperature with Mild 
Antibody Stripping Solution and reprobed for the total 
amount of the respective kinases (ERK2, JNK2, p38) 
and/or β-actin. Using a similar procedure, the membranes 
were probed with antibodies against different NF-κB 
components (IκBα, p-IκBα, p65, p-p65) and reprobed 
with histon H1 and GAPDH.
statistical analysis
Statistical calculations were performed by Student’s t-test or 
analysis of variance with post-tests for multiple comparisons, 
as indicated in the figure legends. Significance was assigned 
to a P-value #0.05.
Results
cXcl8 responses to fluoride and TPa in 
a549 cells
A549 cells were exposed to NaF (0–5 mM) and TPA 
(0–100 nM) for 20 hours. NaF significantly increased 
CXCL8 levels at 2.5 mM, with a maximal response 
(∼6-fold increase) at 3.75 mM, and a subsequent reduc-
tion at 5 mM (Figure 1A). In accordance with previous 
results obtained by propidium iodide and Hoechst 33342 
staining,32 NaF appeared to have a marginal effect on cell 
viability at 3.75 mM, whereas a substantial reduction in 
viability was observed at 5 mM, as judged visually by 
microscopy (a decrease in cell density and an increase in 
rounded/floating cells – not quantified). In comparison, 
TPA was much more potent, with responses in the nM 
range, and with a 20-fold increase in CXCL8 release from 
the cells at 100 nM, as measured after 20 hours’ exposure 
(Figure 1B). No change in viability was observed (not 
quantified). The time–course relationships for CXCL8 
mRNA expression were also examined. NaF (3.75 mM) 
only slowly upregulated CXCL8 mRNA levels (∼2-fold 
at 1 hour; ∼12-fold at 2 hours), reaching a maximal level 
(∼65-fold) at 6–10 hours. In contrast, TPA triggered a 
much more rapid and marked mRNA response for CXCL8, 
with a half-maximal response (45–50-fold) at ∼1 hour, 
a peak at 2 hours (∼90-fold), and then a progressive decline 
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Figure 1 concentration-dependent release of cXcl8.
Notes: cXcl8 after exposure to (A) naF and (B) TPa. a549 cells were exposed to naF (0–5 mM) and TPa (0–100 nM) for 20 hours, and assessed for the release of 
cXcl8 by elIsa. The data represent the mean ± seM of three independent experiments. *significant increase of cXcl8 release; P#0.05. One-way anOVa with Dunnett’s 
multiple comparisons test. The statistics were performed on log-transformed data.
Abbreviations: cXcl8, interleukin-8; naF, sodium fluoride; TPa, 12-O-tetradecanoylphorbol-13-acetate; elIsa, enzyme-linked immunosorbent assay; seM, standard 
error of the mean; anOVa, analysis of variance.
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Figure 2 Time-dependent increase in cXcl8 mRna expression in a549 cells upon 
exposure to naF and TPa.
Notes: a549 cells were exposed to 3.75 mM of naF and 100 nM of TPa for up to 
10 hours, and assessed for cXcl8 mRna by real-time PcR. The data represent 
the mean ± seM of four independent experiments. *significant increase (P,0.05) 
in cXcl8 mRna. #significantly different (P,0.05) from the cXcl8 increase in 
TPa-treated cells. Two-way anOVa with Šidák’s multiple comparisons test. The 
statistics were performed on log-transformed data.
Abbreviations: cXcl8, interleukin-8; naF, sodium fluoride; TPa, 12-O-
tetradecanoylphorbol-13-acetate; mRna, messenger Rna; PcR, polymerase chain 
reaction; seM, standard error of the mean; anOVa, analysis of variance.
up to 10 hours (Figure 2). The cumulative mRNA response 
for NaF and TPA seemed to be of approximately the same 
magnitude for up to 10 hours.
Importance of time of exposure for the 
cXcl8 responses
To assess whether short-term or prolonged signaling was required 
for the CXCL8 responses triggered by NaF and TPA, the culture 
medium was removed from the A549 cell cultures after incuba-
tion for 0.5 hour, 1 hour, 3 hours, 4 hours, 6 hours, 8 hours, and 
10 hours. The cells were subsequently washed (three times) 
and resupplemented with fresh medium up to the time point 
for CXCL8 analysis at 20 hours. These experiments showed 
only a slight increase in CXCL8 responses with medium shift 
after 0.5–3 hours for NaF  exposure. Further, after medium shift 
at 4–6 hours, the response seemed to be approximately half of 
the response in the cells cultured for 20 hours without medium 
replacement (Figure 3A), suggesting that prolonged signaling 
was required for the NaF-induced response. For TPA exposure, 
on the other hand, the media shift as early as 30 minutes did not 
reduce the maximal CXCL8 release; it was even higher when 
TPA was removed from the cells (Figure 3B), suggesting that 
the early signaling was sufficient.
Involvement of MaPK in naF- versus  
TPa-induced cXcl8 release
We have previously shown that NaF induced a time- and 
concentration-dependent increase in the activation/ 
phosphorylation of the MAPKs ERK1/2, p38, and JNK, 
with a persistent increase in the period from 1–4 hours 
in A549 cells.8,9,33 In the present study, we compared the 
effects of NaF (3.75 mM) and TPA (100 nM) in the same 
experiments on the duration of MAPK phosphorylation 
upon exposure up to 4 hours for NaF and TPA, as assessed 
by Western analysis (Figure 4). TPA strongly enhanced 
ERK1/2 phosphorylation, with a maximum response 
already noted after 15–30 minutes. After 2 hours, the TPA-
induced ERK1/2 phosphorylation was diminished, but it 
remained elevated compared to the control at least 4 hours 
after exposure (Figure 4Ab). NaF induced a much weaker, 
although sustained, ERK1/2 phosphorylation, with relatively 
similar levels from 15 minutes to 4 hours (∼2.5%–5% of the 
maximal value for TPA) (Figure 4Aa). Thus, the ERK1/2 
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phosphorylation after TPA exposure was ∼25-fold higher 
than after NaF exposure. In contrast, NaF exposure led to a 
stronger induction of p38 phosphorylation, with a distinct 
and sustained 3-fold increase lasting from 1–4 hours after 
exposure (Figure 4Ba), whereas TPA only weakly and tran-
siently affected p38 phosphorylation, peaking at 30 minutes 
(∼1.7-fold increase), returning to control  levels after 1 hour 
(Figure 4Bb). Furthermore, NaF induced a very strong 
JNK1/2 phosphorylation (∼20-fold) after 1 hour, which 
sharply declined at 2 hours (Figure 4Ca). TPA induced a 
low-to-moderate and transient JNK1/2 response, peaking 
at 15 minutes, returning to background levels after 1 hour 
(Figure 4Cb).
Selective pharmacological MAPK inhibitors were then 
used to assess the role of the three MAPK cascades in 
TPA-induced CXCL8 responses in A549 cells. Figure 5A 
shows that pretreatment with the MEK/ERK1/2 inhibitor 
PD98059 (25 µM) reduced the responses substantially. 
The p38 inhibitor SB202190 (10 µM) affected CXCL8 
release from TPA-exposed cells marginally, whereas the 
JNK1/2 inhibitor SP600125 (20 µM) seemed to slightly 
reduce the response, but this was not statistically significant 
(Figure 5A). Similarly, JNK2 silencing with siRNA only 
resulted in a slight, statistically nonsignificant reduction in 
TPA-induced CXCL8 (Figure 5B). The effect of siRNA on 
the JNK2 levels is shown in Figure 5C. Of note, the level 
of inhibition of TPA-induced CXCL8 by the three MAPK 
inhibitors appeared to reflect their activation level by TPA 
(Figure 4). Thus, the failure of SB202190 and SP600125 
(and siJNK2) to elicit a statistically significant suppression 
of TPA-induced CXCL8 was likely due to a too low activa-
tion of p38 and JNK in TPA-exposed cells. In Table 1, the 
percentage inhibition obtained by PD98059, SB202190, and 
SP9000125 in TPA-exposed cells are compared to similar 
experiments in NaF-exposed cells, based upon our previ-
ously published study.8
Involvement of nF-κB activation in 
fluoride- versus TPa-induced cXcl8 
release
IκBα degradation and p65 phosphorylation and 
translocation
In Figure 6A, the time courses for fluoride- and TPA-
induced IκBα degradation are presented. The IκBα levels 
were only slightly reduced during the first hour of NaF (3.75 
mM) exposure, but more strongly diminished (50%–60%) 
at 2–4 hours (Figure 6Aa). After TPA (100 nM) exposure, 
the IκBα levels were abruptly, but transiently, reduced 
(∼90% reduction) after 30 minutes, already returning to 
initial levels after 2 hours’ exposure (Figure 6Ab). Similarly, 
TPA induced a more marked increase in IκBα phosphoryla-
tion than did NaF in the period up to 1–2 hours, with the 
increase in IκBα phosphorylation preceding the decline 
in IκBα levels (data not shown). NaF elicited a gradual 
phosphorylation of p65, increasing from 30 minutes after 
exposure and reaching a sustained and maximal response 
(∼2-fold) from 1–4 hours (Figure 6Ba). In contrast, TPA 
induced a rapid  phosphorylation of p65, already peaking 
after 15–30 minutes (∼3-fold increase), and gradually 
returning to background levels from 1–2 hours after expo-
sure (Figure 6Bb). The time course for p65 translocation 
from the cytosol to the nuclei after NaF and TPA exposure 
is presented in Figure 6C. Upon NaF exposure, no transloca-
tions were observed at 15 minutes and 30 minutes, whereas 
the highest level of translocation was observed at 2 hours 
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Figure 4 Time-dependent changes of MaPK eRK1/2, p38, and JnK1/2 phosphorylation upon naF and TPa exposure.
Notes: (A) MaPK eRK1/2, (B) p38, and (C) JnK1/2. a549 cells were exposed to (Aa, Ba, and Ca) naF (3.75 mM) and (Ab, Bb, and Cb) TPa (100 nM) for the time 
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kinase; MaPK, mitogen-activated protein kinase.
(2.2-fold compared to untreated controls), followed by a 
reduction at 4 hours (Figure 6Ca). TPA exposure resulted 
in a rapid and more marked translocation to the nuclei, 
with ∼4-fold increase already observed after 30 minutes, 
and with a persistent response (.3-fold) up to 4 hours 
(Figure 6Cb).
effect of nF-κB inhibitors on the naF- and  
TPa-induced cXcl8 responses
The degradation of IκBα may be prevented by different 
proteosomal inhibitors,42–46 and this has been demon-
strated to affect the cytokine responses to different agents 
including TPA.46 In initial experiments, we pretreated 
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the cells with curcumin, a well-known proteosomal 
inhibitor,44–46 and they were exposed to NaF or TPA. 
Curcumin substantially reduced the fluoride- and TPA-
induced IκBα degradation (Figure 7A) and abolished the 
p65 phosphorylation, as assessed in cell lysates (Figure 
7B) and p65 translocation to the nuclei (Figure 7C) after 
exposure to both agents. Furthermore, curcumin almost 
completely abolished the CXCL8 response to both NaF 
and TPA (Figure 8D). However, since curcumin has been 
reported to inhibit MAPKs and other signaling systems,46 
we examined the concentration-dependent effects of 
other well-established proteosomal inhibitors, such as 
BAY11-7082, MG132, and PDTC, known to inhibit IκBα 
Table 1 The relative effect of MaPK inhibitors on naF- and 
TPa-induced cXcl8 release
Inhibitor % inhibition of CXCL8 release
NaF TPA
PD98059 43.6 55.4
sB202190 41.0 12.4ns
sP600125 58.5 32.6ns
Notes: The table compares the percent inhibition of cXcl8 release by the p38 
inhibitor sB202190 (10 µM), the eRK1/2 inhibitor PD98059 (25 µM), and the 
JnK1/2-inhibitor sP600125 (20 µM) in a549 cells exposed to 3.75 mM of naF8 or 
100 nM of TPa for 20 hours. nsnot statistically significant. Data from Refsnes M, 
skuland T, schwarze Pe, Øvrevik J, låg M. Fluoride-induced Il-8 release in human 
epithelial lung cells: relationship to egF-receptor-, sRc- and MaP-kinase activation. 
Toxicol Appl Pharmacol. 2008;227(1):56–67.8 
Abbreviations: MaPK, mitogen-activated protein kinase; naF, sodium fluoride; TPa, 
12-O-tetradecanoylphorbol-13-acetate; cXcl8, interleukin-8; eRK, extracellular 
signal-regulated kinase; JnK, c-jun-n-terminal kinase.
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degradation in a range of studies.43,47 For NaF, small, but 
not significant reductions in CXCL8 release were observed 
for BAY11-7082, MG132 and PDTC (Figure 8Aa, Ba and 
Ca). For TPA, PDTC showed a minor, nonsignificant reduc-
tion (Figure 8Cb), whereas BAY11-7082 and MG132 did 
not exert any reduction (Figure 8Ab and Bb). No apparent 
signs of cytotoxicity were observed for the inhibitors. We 
also assessed the potential role of NF-κB in fluoride- and 
TPA-induced responses by using siRNA against p65. The 
NaF- and TPA-induced CXCL8 releases were partially 
suppressed (∼50% and ∼40% reduction, respectively) by 
siRNA, although inhibition of the TPA-induced response 
did not reach statistical significance (Figure 9A). Of note, 
p65 protein levels were almost completely knocked down 
in by siRNA transfection, as assessed by Western blotting 
(Figure 9B).
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effect of MaPK inhibitors on the  
nF-κB-system
To examine whether ERK1/2, JNK1/2, and p38 exerted 
their effect via NF-κB-dependent or independent pathways, 
we examined the ability of selective MAPK inhibitors to 
interfere with NF-κB. Subsequent to NaF exposure, neither 
of the MAPK inhibitors affected the IκBα degradation 
(Figure 10Aa). Whereas the NaF-induced p65 phosphoryla-
tion was partially reduced by the p38 inhibitor, SB202190, 
the ERK inhibitor, PD98059, and JNK inhibitor, SP600125, 
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did not exert any effects (Figure 10Ba). In contrast, the 
NaF-induced p65 translocation was partially reduced by 
all the MAPK inhibitors (Figure 10Ca). With respect to 
TPA exposure, the inhibitors of MAPK appeared to be 
without effects on NF-κB signaling (Figure 10Ab, 10Bb, 
and 10Cb).
Discussion
The present study compared the CXCL8 response to NaF with 
the phorbol ester, TPA – two compounds that show no structural 
similarity, but exhibit different activation patterns of intracel-
lular signaling (slow/rapid; persistent/transient; weak/strong). 
Previously, we have reported on the differential activation of 
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PKC by NaF and TPA in A549 cells,9 whereas the present study 
shows the patterns of MAPK and NF-κB activation in relation 
to CXCL8 induction after exposure to these stimulants.
NaF exposure elicited a moderate but sustained 
phosphorylation of p38, ERK1/2, and the p65 subunit of 
NF-κB, as well as a strong but transient phosphorylation 
of JNK. This was accompanied by a gradual, but sustained 
increase in CXCL8 mRNA levels and a low-to-moderate 
increase in CXCL8 release from A549 cells. Consistent with 
this gradual, sustained activation of intracellular signaling 
pathways and CXCL8 expression, our experiments – with the 
removal of NaF by washing and shift of medium – indicated 
that a long-term/persistent response was required for trig-
gering the NaF-induced CXCL8 response. Furthermore, 
all the three MAPK pathways and NF-κB signaling seem 
involved in CXCL8 regulation in NaF-exposed A549 cells. 
This corroborates and extends previous results showing that 
a combined inhibition of different MAPKs was necessary 
to completely abrogate CXCL8 responses in NaF-exposed 
A549 cells.8
In contrast to NaF, TPA exposure resulted in a rapid, 
strong, but relatively transient increase in phosphorylation of 
ERK1/2, with only marginal effects on p38 and JNK, as com-
pared to NaF. Moreover, TPA also elicited a more transient 
phosphorylation of p65, although p65 nuclear translocation 
appeared to persist longer than in NaF-exposed cells. In 
line with the effects on ERK and p65 phosphorylation, TPA 
also resulted in a rapid, transient increase in CXCL8 mRNA 
levels, accompanied by a strong increase in CXCL8 protein 
release. Contrary to the effects observed in NaF-exposed 
cells, the effects of TPA seemed to be predominately medi-
ated through ERK1/2 and NF-κB signaling, as inhibitors 
of p38 and JNK1/2 had little impact on the TPA-induced 
CXCL8 response. This also contradicts earlier suggestions 
that JNK1/2 signaling is indispensable for inducible CXCL8 
regulation.15 Furthermore, the wash-out experiment showed 
that a short-term exposure to TPA was sufficient to trigger a 
CXCL8 response, suggesting that these early transient sig-
naling events appear to be central and perhaps sufficient to 
elicit the full TPA response. Notably, the wash-out experiment 
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also indicated that CXCL8 responses were reduced upon 
prolonged TPA exposure, as compared to shorter/more acute 
exposure times. The mechanism for this remains obscure, 
but it may be related to time-dependent downregulation/
desensitization of cellular signaling by TPA. In support of 
this, we have previously observed that pretreatment with 
TPA markedly lowered the CXCL8 response to repeated 
TPA exposures.9
The general concept of CXCL8 regulation is that com-
bined activation of all the MAPKs, in addition to NF-κB, 
is required to achieve a maximal activation of the CXCL8 
response.15 Interestingly, the present study shows that TPA, 
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via a rapid and strong activation of ERK in combination with 
NF-κB, induces a strong upregulation of CXCL8 production 
at 20 hours, by far surpassing the CXCL8 response induced 
by the combined, moderate, and sustained activation of the 
different MAPKs in NaF-exposed A549 cells. Although it 
cannot be excluded that activation of additional MAPKs 
(p38 and JNK) would have enhanced the TPA-induced 
CXCL8 response even further, our results show that strong 
activation of ERK1/2 alone, in combination with NF-κB 
signaling, may be sufficient for a marked CXCL8 response. 
Of note, inhibition of ERK1/2 by PD98059 resulted in a 
partial and almost identical reduction of CXCL8 induction 
after both NaF and TPA exposure, while p65 knockdown 
by siRNA omitted a slightly stronger relative suppression 
of NaF-induced CXCL8 release. Thus, the greater CXCL8 
release induced by TPA compared to NaF may not solely be 
due to its stronger effects on ERK1/2- and NF-κB-dependent 
mechanisms. An interesting observation is that even though 
TPA induced a considerably stronger CXCL8 release than 
did NaF when analyzed at 20 hours, the cumulative CXCL8 
mRNA responses in the period up to 10 hours appeared to be 
relatively similar. The reason for this apparent discrepancy 
is unclear, but it may possibly be related to effects at the 
translational level.
Although TPA induced a strong increase in CXCL8 
release (20-fold) compared to NaF (6-fold), it should also be 
noted that the level of CXCL8 induction by TPA is consider-
ably lower than the more than 100-fold increase in CXCL8 
synthesis, which has been reported after exposure with 
cytokines such as IL-1 and TNF-α.15 Such massive increases 
in CXCL8 are believed to require additional mRNA stabiliza-
tion by p38.15 In our present study, p38 was only marginally 
affected by TPA exposure, and in line with the notion that 
p38 activity is required to stabilize CXCL8 mRNA, TPA-
induced CXCL8 mRNA levels dropped rapidly after 2 hours’ 
exposure, which is also when TPA-induced phosphorylation 
of ERK1/2 and p65 returned to basal levels. In contrast, the 
sustained increase in CXCL8 mRNA levels in NaF-exposed 
A549 cells appeared to be accompanied by comparably sus-
tained increases in p38 and NF-κB phosphorylation levels, 
lasting at least up to 4 hours after exposure.
NF-κB is considered to play an important role in CXCL8 
regulation.15 Thus, regulation of the CXCL8 promoter activity 
has been shown to involve a strong cooperation between a 
high-affinity NF-κB site and an activating protein-1 (AP-1) 
recognition sequence.15,48 The AP-1 recognition sequence 
binds proteins like c-jun and c-fos that are activated by 
MAPKs. In accordance with this, the attenuation of NF-κB 
signaling by use of curcumin or siRNA transfection against 
p65 suppressed CXCL8 responses induced by both NaF 
and TPA. However, despite that, silencing of p65 by siRNA 
resulted in an almost complete downregulation of p65 protein 
levels; this only led to a partial (50%) reduction of NaF-
induced CXCL8 and a 40% (and not statistically significant) 
reduction of TPA-induced CXL8 responses in the A549 cells. 
This contrasts the common assumption that NF-κB signaling 
is a prerequisite for inducible CXCL8 regulation.15 Curcumin 
treatment, on the other hand, nearly completely abrogated the 
CXCL8 responses induced by both TPA and NaF. Notably, 
curcumin, which inhibited IκBα degradation, p65 phospho-
rylation, and translocation in our present study, is also known 
to suppress AP-1 and other signaling pathways.44–46 Thus, the 
inhibitory effects of curcumin on NaF- and  TPA-induced 
CXCL8 responses are likely not restricted to NF-κB inhibi-
tion, but they may involve suppression of additional signaling 
pathways such as AP-1. Somewhat surprisingly, a range of 
chemical inhibitors of IκBα degradation commonly used to 
assess NF-κB signaling (MG132, BAY11-7082, and PDTC) 
mostly failed to reduce the CXCL8 responses to TPA or NaF 
treatment, though nonsignificant reductions in the response 
to NaF were observed. Although we did not verify that these 
inhibitors actually prevented IκB degradation, it seems 
unlikely that they all simultaneously failed to function prop-
erly at every concentration tested. A more likely explanation 
is that the lack of convincing inhibitory effects is related to 
unspecific properties of the inhibitors. Almost all of these 
inhibitors have been reported to possess AP-1-stimulating 
activity, which may counteract the effects of reduced NF-κB 
signaling and mask the expected inhibition of the CXCL8 
responses.43,47 Thus, these classical inhibitors of IκBα deg-
radation seem less suited for studies on the role of NF-κB 
in cytokine regulation.
In addition to activating the AP-1 site of the CXCL8 
promoter, MAPKs may also be localized upstream to NF-κB. 
Thus, different MAPK inhibitors have been reported to inter-
fere with the activation of NF-κB upon exposure to different 
agents. Both ERK1/2 and JNK1/2 have been reported as 
upstream activators of NF-κB in IL-1- and TNF-α-exposed 
lung epithelial cells, including A549 cells.12,16,17 ERK1/2 
has previously been reported to regulate NF-κB activation 
in TPA-exposed A549 and U937 cells.18,19 In contrast to 
this, our current findings did not reveal any effects of either 
ERK1/2, p38, or JNK1/2 inhibition on TPA-induced NF-κB 
signaling in the A549 cells. The reason for this discrepancy 
from previous studies remains unclear. However, in NaF-
exposed A549 cells, inhibition of all the three MAPKs 
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partially reduced NF-κB translocation. Moreover, p38 
inhibition also reduced p65 phosphorylation at serine 536 in 
NaF-exposed cells, which is important to CXCL8 expression 
as it promotes coupling of p65 to the basal transcriptional 
machinery.49–51 This observation is consistent with reports of 
p38 regulating p65 Ser536-phosphorylation at the CXCL8 
promoter in pneumococci-stimulated human bronchial epi-
thelial cells.50 Notably, p38 has often been associated with 
post-transcriptional effects on mRNA stabilization, but it may 
also function as an early responder to different toxicants, and 
to be an upstream regulator of the TACE (TGF-α converting 
enzyme)/transforming growth factor-α/epidermal growth 
factor receptor pathway, which has been proposed as a central, 
convergent pathway in innate immunity.52,53
This study is restricted to molecular mechanisms regu-
lating CXCL8 responses to NaF and TPA in A549 cells. 
 Fluoride-induced IL-6 release appears to follow similar time 
course and concentration–response relationships as CXCL8, 
suggesting that comparable mechanisms may be involved in the 
regulation of these cytokines.26 Although we have not assessed 
the regulatory mechanism for fluoride- and TPA-induced IL-6, 
we have previously found that the p38 inhibitor, SB202190, 
elicited the identical inhibition of IL-6 and CXCL8, while 
the ERK1/2 inhibitor, PD98059, was somewhat less efficient 
in inhibiting IL-6 than CXCL8, from stone particle-exposed 
A549 cells.54 Despite that, the A549 cell line is one of the best 
described lung cell models and is commonly used for toxicity 
testing and pharmacological studies, the generalization of the 
results obtained from immortalized cell lines should be done 
with great caution. Thus, one cannot exclude the possibility 
that NaF and TPA may exert their effects on CXCL8 through 
different mechanisms in normal lung cells. However, we have 
previously shown by use of other exposure agents (crystalline 
silica) that the role of MAPKs in the regulation of CXCL8 
release from A549 cells resembles their role in the regulation 
of MIP-2 release from primary rat type 2 cells.55
Overall, the potential of different toxicants and other 
activators to induce CXCL8 responses seems to depend upon 
the respective signals elicited and the magnitude and duration 
of the signaling. Our results suggest that the stronger release 
of CXCL8 to TPA than to NaF after 20 hours’ exposure in 
lung epithelial cells (A549 cells) seems ascribed to the early 
and strong upregulation of the ERK1/2 and NF-κB activation 
induced by TPA. For NaF, both the magnitude and persistency 
of the signaling seem important, involving the combined 
activation of ERK1/2, p38, JNK, and NF-κB pathways. Our 
findings also underscore that a strong, rapid, and relatively 
transient activation of ERK1/2 in combination with NF-kB 
may be sufficient to induce a strong induction of CXCL8, 
which may exceed the effects of a more moderate ERK1/2 
activation in combination with the activation of p38, JNK, 
and NF-κB.
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